OMERACT 7
7th International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials
Asilomar, California, USA
May 8–12, 2004
Introduction
C.V. Strand, L.S. Simon, P. Tugwell, P. Brooks, M. Boers ......... 2014
PDF
Modules
Minimal Disease Activity for RA: A Preliminary Definition
G.A. Wells, M. Boers, B. Shea, et al ......... 2016
PDF
Minimal Clinically Important Difference, Low Disease Activity State, and Patient Acceptable Symptom State: Methodological Issues
F. Tubach, G.A. Wells, P. Ravaud, M. Dougados ......... 2025
PDF
Challenges and Progress in Adverse Event Ascertainment and Reporting in Clinical Trials
M.N.D. Lassere, K.R. Johnson, for the OMERACT Drug Safety Working Group .........2030
PDF
Generic Patient Self-Report and Investigator Report Instruments of Therapeutic Safety and Tolerability
M.N.D. Lassere, K.R. Johnson, S. Van Santen, et al .........2033
PDF
Standardized Assessment of Adverse Events in Rheumatology Clinical Trials: Summary of the OMERACT 7 Drug Safety Module Update
M.N.D. Lassere, K.R. Johnson, M. Boers, et al .........2037
PDF
Application of the OMERACT Filter to Scoring Methods for MRI of the Sacroiliac Joints and the Spine. Recommendations for a Research Agenda at OMERACT 7
D.M.F.M van der Heijde, R.B.M. Landewé, K-G.A. Hermann, et al.........2042
PDF
Selection of a Method for Scoring Radiographs for AS Clinical Trials, by the Assessment in AS Working Group and OMERACT
D.M.F.M. van der Heijde, R.B.M. Landewé, and the ASAS Working Group.........2048
PDF
Scoring Sacroiliac Joints by MRI. A Multiple-Reader Reliability Experiment
R.B.M. Landewé, K-G.A. Hermann, D.M.F.M. van der Heijde, et al.........2050
PDF
MRI of Inflammatory Lesions in the Spine in AS Clinical Trials: Is Paramagnetic Contrast Medium Necessary?
K-G.A. Hermann, R.B.M. Landewé, J. Braun, D.M.F.M. van der Heijde.........2056
PDF
Workshops
Progress since OMERACT 6 on Including Patient Perspective in Rheumatoid Arthritis Outcome Assessment
J.R. Kirwan, M. Ahlmén, M. De Wit, et al.........2246
PDF
Incorporating the Patient Perspective into Outcome Assessment in Rheumatoid Arthritis — Progress at OMERACT 7
J.R. Kirwan, S.E. Hewlett, T. Heiberg, et al.........2250
PDF
Attributes and Skills of an Effective Musculoskeletal Consumer
P.S. Tugwell, A. Wilson, P.M. Brooks, et al.........2257
PDF
Outcome Measures in Psoriatic Arthritis
D.D. Gladman, P.J. Mease, G. Krueger, et al.........2262
PDF
Fibromyalgia Syndrome
P.J. Mease, D.J. Clauw, L.M. Arnold, et al.........2270
PDF
Special Interest Groups
Concomitant Therapies as an Outcome Measure. Part 1: Drugs
L. Gossec, R.B.M. Landewé, J-F. Maillefert, M. Dougados.........2447
PDF
Concomitant Therapy: An Outcome Variable for Musculoskeletal Disorders? Part 2: Total Joint Replacement in Osteoarthritis Trials
J-F. Maillefert, G.A. Hawker, L. Gossec, et al.........2449
PDF
Outcome Measures for Acute and Chronic Gout
H.R. Schumacher, L.N. Edwards, F. Perez-Ruiz, et al.........2452
PDF
Measurement of Joint Space Width and Erosion Size
J.T. Sharp, D.M.F.M van der Heijde, J. Angwin, et al.........2456
PDF
Magnetic Resonance Imaging in Rheumatoid Arthritis — Advances and Research Priorities
M. Østergaard, F.M. McQueen, P. Bird, et al.........2462
PDF
The Evidence for Magnetic Resonance Imaging as an Outcome Measure in Proof-of-Concept Rheumatoid Arthritis Studies
P.G. Conaghan, F.M. McQueen, C.G. Peterfy, et al.........2465
PDF
The Design and Evaluation of Psychoeducational/Self-Management Interventions
K. Mulligan, S.P. Newman, E. Taal, M. Hazes, J.J. Rasker.........2470
PDF
Reconciling Subject Differences in Recruitment to Clinical Trials and Clinical Practice
K.L. Hyrich, D.P.M. Symmons, A.J. Silman.........2475
PDF
Scleroderma — Developing Measures of Response
D.E. Furst, D. Khanna, M. Mattucci-Cerinic, A.J. Silman, P.A. Merkel, I. Foeldvari.........2477
PDF
Synovial Tissue Analysis in Clinical Trials
B. Bresnihan, D. Baeten, G.S. Firestein, et al.........2481
PDF
Musculoskeletal Ultrasound Including Definitions for Ultrasonographic Pathology
R.J. Wakefield, P.V. Balint, M. Szkudlarek, et al.........2485
PDF
Current Status of Outcome Measures in Vasculitis: Focus on Wegener’s Granulomatosis and Microscopic Polyangiitis. Report from OMERACT 7
P.A. Merkel, P. Seo, P. Aries, et al.........2488
PDF
Acknowledgments.........2496
PDF